Log in or Sign up for Free to view tailored content for your specialty!
Respiratory Infections News
FDA authorizes COVID-19 vaccines for youngest children
The FDA announced Friday that it authorized the emergency use of Moderna and Pfizer-BioNTech’s COVID-19 vaccines for children as young as 6 months old.
Respiratory virus trends in hospitals during COVID-19 mirrored trends in community
Trends in respiratory viral infections in hospitals mirrored trends in the community during the COVID-19 pandemic, “suggesting that hospital interventions alone did not significantly affect” their incidence, researchers reported.
Log in or Sign up for Free to view tailored content for your specialty!
Q&A: Does vaccination prevent long COVID?
Vaccination may not fully protect people from long COVID symptoms if they experience a breakthrough infection, according to a study published recently in Nature Medicine.
FDA committee recommends COVID-19 vaccines for youngest children
An FDA advisory committee on Wednesday unanimously recommended that Moderna and Pfizer-BioNTech’s COVID-19 vaccines be authorized for children as young as 6 months old.
Fauci tests positive, is experiencing mild COVID-19 symptoms, NIAID says
Anthony S. Fauci, MD, has tested positive for COVID-19 and is experiencing mild symptoms, the National Institute of Allergy and Infectious Diseases said Wednesday.
FDA committee unanimously backs Moderna vaccines for children, adolescents
An FDA advisory committee on Tuesday unanimously backed Moderna’s COVID-19 vaccines for children and adolescents aged 6 to 17 years.
Latent TB testing, positivity increased throughout 2021
WASHINGTON — Data collected between 2019 and 2021 assessing trends in latent tuberculosis testing and positivity showed increased rates correlating with COVID-19 testing, researchers said at ASM Microbe.
Evidence builds that pandemic negatively impacted STI testing
Researchers at ASM Microbe presented more evidence that there was a decline in STI testing and prevention measures in the United States during the COVID-19 pandemic.
SARS-CoV-2 may increase risk for oral C. albicans infection, researchers say
The presence of SARS-CoV-2 in the mouth may compromise the production of an important antimicrobial peptide and make patients more susceptible to oral Candida albicans infection, researchers said at ASM Microbe.
MIS-C risk during omicron substantially lower than previous waves
The risk for multisystem inflammatory syndrome in children after infection with SARS-CoV-2 was substantially lower during the omicron wave compared with other variants, researchers from Denmark reported in JAMA Pediatrics.